Drawing for LENTISHIELD

USPTO serial 78841048

LENTISHIELD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHANG, KATHERINE S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LENTISHIELD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric S. Marzluf

Eric S. Marzluf Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.1635 Market Street11th Floor - Seven Penn CenterPhiladelphia, PA 19103-2212

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies for in vitro scientific or research useACTIVE—
005Cells for medical or clinical use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsACTIVE—
040Contract manufacturing in the field of biopharmaceuticals, including lentiviral vectorsACTIVE—
042Development of new technology for others in the field of drug delivery and validation, gene expression and delivery, genomics research, protein and monoclonal antibody production; Medical and scientific research, namely conducting clinical trials; Pharmaceutical drug development services; Structural and functional anaylisis of genomesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 11, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 6, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 23, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 23, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 31, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2006DOCKASSIGNED TO EXAMINER—
Oct 11, 2006NPUBNOTICE OF PUBLICATION—
Sep 15, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 15, 2006ALIEASSIGNED TO LIE—
Sep 2, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 2006DOCKASSIGNED TO EXAMINER—
Mar 24, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance